Format

Send to

Choose Destination
See comment in PubMed Commons below
Kaohsiung J Med Sci. 2004 Jun;20(6):295-301.

Obsessive-compulsive symptoms associated with clozapine and risperidone treatment: three case reports and review of the literature.

Author information

1
Department of Psychiatry, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.

Abstract

Treatment-emergent obsessive-compulsive symptoms (OCSs) have raised concern since the widespread introduction of serotonin-dopamine antagonists (SDAs) for the treatment of schizophrenia. Further investigations of SDA-emergent OCSs and their response to anti-obsessional agents will be beneficial for clinicians in helping patients who suffer from this problem. We present three cases of schizophrenia in which distressing OCSs occurred during clozapine or risperidone treatment. OCSs were assessed consecutively using the Yale-Brown Obsessive-Compulsive Scale. The OCSs of these three patients were responsive to anti-obsessional agents, including fluvoxamine, clomipramine, and paroxetine. We also review the current literature and discuss the possible pathophysiology and psychopathology of SDA-emergent OCSs.

PMID:
15253471
DOI:
10.1016/S1607-551X(09)70121-4
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center